Correlation Study of Corneal Nerve Changes and Dry Eye in Contact Lens Wearers

Sponsor
Peking University Third Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT04663529
Collaborator
(none)
60
1
12
5

Study Details

Study Description

Brief Summary

This study aims to analyze the changes of corneal nerve morphology and function in contact lens-related dry eye(CLADE) patients and further discuss the role of corneal nerve in the genesis and development of CLADE.

Condition or Disease Intervention/Treatment Phase
  • Other: contact lens

Detailed Description

33 daily disposable soft contact lens wearers with dry eye disease(DED), 33 DED without contact lens wear and 33 normal control subjects will be involved in study. One experienced ophthalmologist will evaluate the DED symptoms and signs, which include ocular surface disease index(OSDI), tear film breakup time(TBUT), Schirmer Ⅰ test, corneal fluorescein staining, lissamine green staining and meibomian gland dropout rate. After evaluating, corneal sensitivity are measured using a Cochet-Bonnet aesthesiometer. Corneal nerve morphology will be assessed in the right eye using in vivo confocal microscopy(IVCM). Fifteen to twenty minutes after IVCM, 20μL of basal tears will be collected from the inferior meniscus of each participant to test tear neuropeptides. Then investigators analyse the correlation of corneal nerve changes and DED symptoms and signs.

Study Design

Study Type:
Observational
Actual Enrollment :
60 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Correlation Study of Corneal Nerve Changes and Dry Eye in Contact Lens Wearers
Actual Study Start Date :
Oct 1, 2020
Actual Primary Completion Date :
May 1, 2021
Actual Study Completion Date :
Oct 1, 2021

Arms and Interventions

Arm Intervention/Treatment
CLADE

contact lens wearers with DED

Other: contact lens
daily disposable soft contact lens

non-CLADE

DED without contact lens wear

NC

normal control

Outcome Measures

Primary Outcome Measures

  1. sub-basal corneal nerve density [baseline]

    Sub-basal corneal nerve plexus image will be acquired using a laser scanning confocal microscope. Sub-basal nerve fiber density will be calculated from a manual trace of the length of all nerve fibers in each 1 mm2 image.

  2. sub-basal corneal nerve tortuosity [baseline]

    Sub-basal corneal nerve plexus image will be acquired using a laser scanning confocal microscope. Sub-basal nerve tortuosity will be assessed using a grading scale separately by two experienced ophthamologist.

Secondary Outcome Measures

  1. ocular surface disease index(OSDI) [baseline]

    OSDI is one of the most frequently used questionnaires for evaluation of DED. This includes 12 questions which measure the frequency of symptoms over the recent week, and the scores range from 0 to 100.

  2. Tear break-up time (TBUT) [baseline]

    TBUT is the time from normal blinking to the first appearance of a break in the tear film.

  3. Schirmer Ⅰ test (SⅠt) [baseline]

    The Schirmer I test is performed using sterile strips without anesthesia. The strips are placed in the lateral part of the inferior fornix of the eye for 5min and the extent of tear flow down was measured in millimeters.

  4. Corneal fluorescein staining [baseline]

    The degree of fluorescein staining of the cornea was evaluated using the National Eye Institute (NEI) scale of five corneal regions (central, superior, temporal, nasal, and inferior).

  5. Lissamine green staning [baseline]

    To grade the temporal zone, the subject looks nasally; to grade the nasal zone the subject looks temporally. The upper and lower conjunctiva can also be graded.

  6. meibomian gland droupout rate [baseline]

    meibomian gland evaluation

  7. corneal sensitivity [baseline]

    Corneal sensitivity will be measured in the right eye only using the Cochet-Bonnet aesthesiometer and the ascending method of limits to determine the threshold of stimulus detection.

  8. the concentration of substance P [baseline]

    20μL of basal tears will be collected from the inferior meniscus of each subject to test substance P. Substance P levels will be quantified by competitive enzyme-linked immunosorbent assays.

  9. the concentration of CGRP [baseline]

    CGRP levels will be quantified by competitive enzyme-linked immunosorbent assays.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 40 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Age 18years to 40 years;

  • Male or female DED patients based on Chinese Dry Eye Diagnosis Standard (2020) with or without contact lens wear;

  • Provision of written informed consent.

Exclusion Criteria:
  • Presence of any of the following conditions: active ocular infection, ocular inflammation, active ocular allergy, ocular surgical history, laser treatment in the last 3 months, Meibomian function (MGD) over grade 2 (the grade is according to the report of the International Workshop on MGD in 2011), severe blepharitis or obvious inflammation of the eyelid margin, which in the judgment of the investigator may interfere with the interpretation of the study results

  • Pregnant and lactating women, or those planning a pregnancy over the course of the study

  • Uncontrolled systemic disease

  • Suffer from diseases that may affect corneal nerves, such as keratoconus, trigeminal neuralgia, allergic conjunctivitis, etc.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Peking University Third Hospital Beijing Beijing China 100191

Sponsors and Collaborators

  • Peking University Third Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Peking University Third Hospital
ClinicalTrials.gov Identifier:
NCT04663529
Other Study ID Numbers:
  • CLADE
First Posted:
Dec 11, 2020
Last Update Posted:
Jun 1, 2022
Last Verified:
Sep 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Peking University Third Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 1, 2022